Unicycive Therapeutics (UNCY) Return on Equity [ROE] (2021 - 2026)
Unicycive Therapeutics' Return on Equity [ROE] came in at -69.73% for Q2 2026, up 142.66 percentage points from -212.39% a year earlier and up 15.22 percentage points from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Unicycive Therapeutics' Return on Equity [ROE] was -151.89%, up 1555.84 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of -12.82 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -1707.73% in FY2024, -225.47% in FY2022 (-86.40 pp) and -139.07% in FY2021.
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2021.
- Business Quant data shows UNCY's Return on Equity [ROE] at -84.95% (Q1 2026), -84.45% (Q4 2025) and -113.69% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Unicycive Therapeutics | 104.44 Mn | -95.54 Mn | - | -69.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.73% |
| Mar 31, 2026 | -84.95% |
| Dec 31, 2025 | -84.45% |
| Sep 30, 2025 | -113.69% |
| Jun 30, 2025 | -212.39% |
| Mar 31, 2025 | -316.01% |
| Dec 31, 2022 | -868.17% |
| Sep 30, 2022 | -213.02% |
| Jun 30, 2022 | -126.93% |
| Mar 31, 2022 | -81.80% |
| Dec 31, 2021 | -54.14% |
| Sep 30, 2021 | -104.54% |
API Access
Unicycive Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();